Evaluation of Generic versus Original Prostaglandin Analogues in the Treatment of Glaucoma A Systematic Review and Meta-Analysis

被引:5
作者
Steensberg, Alvilda T. [1 ]
Mullertz, Olivia O. [1 ]
Virgili, Gianni [2 ,3 ]
Azuara-Blanco, Augusto [4 ]
Kolko, Miriam [1 ,5 ]
机构
[1] Univ Copenhagen, Dept Drug Design & Pharmacol, Copenhagen, Denmark
[2] Univ Firenze, Dept Neurosci Psychol Drug Res & Child Hlth, Careggi, Italy
[3] AOU, Careggi, Italy
[4] Queens Univ Belfast, Ctr Publ Hlth, Belfast, Antrim, North Ireland
[5] Copenhagen Univ Hosp, Rigshosp Glostrup, Dept Ophthalmol, Glostrup, Denmark
来源
OPHTHALMOLOGY GLAUCOMA | 2020年 / 3卷 / 01期
关键词
OPEN-ANGLE GLAUCOMA; PHYSICAL-PROPERTIES; LATANOPROST; MEDICATIONS; IMPAIRMENT; XALATAN(R); TRIALS;
D O I
10.1016/j.ogla.2019.10.002
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Topic: An evaluation of the efficacy and tolerability of generic prostaglandin analogues (PGAs) compared with their original counterpart. Clinical Relevance: This systematic review was initiated to enlighten ophthalmologists and patients in the use of original and generic ophthalmic solutions. Methods: A literature search was conducted on PubMed, EMBASE, MEDLINE, Clinicaltrials.gov, and the World Health Organization International Clinical Trials Registry Platform, along with a manual search, from the marketing of the first PGA, latanoprost, in 1995 to the present. Randomized controlled trials comparing an original PGA with its generic counterpart were included. The last literature search was conducted in June 2019. Risk of bias was assessed by 2 independent reviewers using the Cochrane Handbook for Systematic Reviews Tool. The primary outcome was reduction of intraocular pressure (IOP) from baseline. Secondary outcomes included tolerability, ocular surface health, quality of life, disease progression, and cost-effectiveness. Meta-analysis of the primary outcome was planned. Results: Of 385 screened articles, 6 were included in a broad characterization and in the meta-analysis. A total of 619 patients were enrolled. The duration of the studies ranged from 3 to 16 weeks. Meta-analysis of all 6 studies denied any clinically significant difference in efficacy, and the 95% confidence interval included nil (-0.50 to 0.04 mmHg). The evidence was of moderate certainty because of unclear or high risk of bias in all studies. There were no reported differences in tolerability. Conclusions: Trials comparing original and generic PGAs did not show a clinically significant difference in IOP-lowering effect or tolerability. However, the quality of the trials is suboptimal. Overall, there is uncertainty, and further research is needed to confirm equivalence. (C) 2019 by the American Academy of Ophthalmology
引用
收藏
页码:51 / 59
页数:9
相关论文
共 32 条
[1]   Latanoprost 0.005% test formulation is as effective as Xalatan® in patients with ocular hypertension and primary open-angle glaucoma [J].
Allaire, Catherine ;
Dietrich, Alice ;
Allmeier, Helmut ;
Grundmane, Iveta ;
Mazur-Piotrowska, Grazyna ;
Neshev, Pepo ;
Kahle, Gunther .
EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2012, 22 (01) :19-27
[2]   Evaluation of physical properties and dose equivalency of generic versus branded latanoprost formulations [J].
Angmo, Dewang ;
Wadhwani, Meenakshi ;
Velpandian, Thirumurthy ;
Kotnal, Ankita ;
Sihota, Ramanjit ;
Dada, Tanuj .
INTERNATIONAL OPHTHALMOLOGY, 2017, 37 (02) :423-428
[3]  
[Anonymous], Generic and hybrid medicines
[4]  
[Anonymous], 2019, CORE OUTCOME MEASURE
[5]  
[Anonymous], VEJLEDNING APOTEKETS
[6]  
[Anonymous], Orange Book: Approved drug products with therapeutic equivalence evaluations
[7]   Principles of pharmacology in the eye [J].
Awwad, Sahar ;
Ahmed, Abeer H. A. Mohamed ;
Sharma, Garima ;
Heng, Jacob S. ;
Khaw, Peng T. ;
Brocchini, Steve ;
Lockwood, Alastair .
BRITISH JOURNAL OF PHARMACOLOGY, 2017, 174 (23) :4205-4223
[8]   GRADE guidelines: 3. Rating the quality of evidence [J].
Balshem, Howard ;
Helfand, Mark ;
Schuenemann, Holger J. ;
Oxman, Andrew D. ;
Kunz, Regina ;
Brozek, Jan ;
Vist, Gunn E. ;
Falck-Ytter, Yngve ;
Meerpohl, Joerg ;
Norris, Susan ;
Guyatt, Gordon H. .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2011, 64 (04) :401-406
[9]   Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis [J].
Bourne, Rupert R. A. ;
Flaxman, Seth R. ;
Braithwaite, Tasanee ;
Cicinelli, Maria V. ;
Das, Aditi ;
Jonas, Jost B. ;
Keeffe, Jill ;
Kempen, John H. ;
Leasher, Janet ;
Limburg, Hans ;
Naidoo, Kovin ;
Pesudovs, Konrad ;
Resnikoff, Serge ;
Silvester, Alex ;
Stevens, Gretchen A. ;
Tahhan, Nina ;
Wong, Tien Y. ;
Taylor, Hugh R. .
LANCET GLOBAL HEALTH, 2017, 5 (09) :E888-E897
[10]   Ability of Bottle Cap Color to Facilitate Accurate Patient-Physician Communication Regarding Medication Identity in Patients with Glaucoma [J].
Dave, Pujan ;
Villarreal, Guadalupe, Jr. ;
Friedman, David S. ;
Kahook, Malik Y. ;
Ramulu, Pradeep Y. .
OPHTHALMOLOGY, 2015, 122 (12) :2373-2379